Galderma stock: dermatology group at EUR 190.63 ahead of the Xetra open

Published on 10/19/2026 at 08:06 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Galderma develops dermatology products across three business areas. At Lang & Schwarz the stock trades pre-market at EUR 190.63 on October 19, 2026.

Business model and market context

Galderma operates across Injectable Aesthetics, Dermatological Skincare and Therapeutic Dermatology.
The home market is the SMI in Switzerland.
Galderma stock trades pre-market at EUR 190.63 at 8:04 a.m. CEST at Lang & Schwarz on October 19, 2026.

Galderma, CH1335392721, Illustration mit AI erstellt.

Galderma develops and sells dermatology products through Injectable Aesthetics, Dermatological Skincare and Therapeutic Dermatology, according to the company description in a Galderma release. Galderma stock trades pre-market at EUR 190.63 at 8:04 a.m. CEST at Lang & Schwarz on October 19, 2026.

Ahead of the Xetra open

The continuously updated real-time quote of Galderma stock shows the further course from the Xetra open at 9:00 a.m. CEST.

The group and its market

Galderma earns revenue in Injectable Aesthetics, Dermatological Skincare and Therapeutic Dermatology, serving the dermatology market, as described by the company in its October 14, 2026 release.

Market context: Market report SMI.

More news and analysis on Galderma stock